Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Katrien P. M. Pouls, Monique C. J. Koks-Leensen, Willem J. J. Assendelft, Mathilde Mastebroek & Geraline L. Leusink. (2022) Primary mental healthcare for adults with mild intellectual disabilities: a Dutch database study. European Journal of General Practice 28:1, pages 234-241.
Read now
Read now
Janelle Weise & Julian N. Trollor. (2018) Preparedness and training needs of an Australian public mental health workforce in intellectual disability mental health. Journal of Intellectual & Developmental Disability 43:4, pages 431-440.
Read now
Read now
Steven R. Erickson, Drita Nicaj & Sasha Barron. (2018) Complexity of medication regimens of people with intellectual and developmental disabilities. Journal of Intellectual & Developmental Disability 43:3, pages 351-361.
Read now
Read now
Articles from other publishers (58)
F. Nurminen, H. Rättö, M. Arvio, A. Teittinen, H. T. Vesala & L. Saastamoinen. (2022) Medicine use in people with intellectual disabilities: a Finnish nationwide register study. Journal of Intellectual Disability Research 67:12, pages 1291-1305.
Crossref
Crossref
Nathan J. Wilson, Tiffany Patterson-Norrie, Amy Villarosa, Hanny Calache, Linda Slack-Smith, Shwetha Girish Kezhekkekara & Ajesh George. (2023) Supporting the oral health of people with intellectual disability: A survey of disability staffs' knowledge, perceptions, disability service barriers, and training. Disability and Health Journal, pages 101536.
Crossref
Crossref
Milou van den Bemd, Maarten Cuypers, Bianca Schalk, Geraline Leusink & Erik Bischoff. (2023) Chronic disease management in patients with and without intellectual disabilities: a matched study in Dutch general practice. British Journal of General Practice, pages BJGP.2023.0029.
Crossref
Crossref
Menghuan Song, Bryn S Rubin, Justin WT Ha, Robert S Ware, Tan N Doan & David Harley. (2023) Use of psychotropic medications in adults with intellectual disability: A systematic review and meta-analysis. Australian & New Zealand Journal of Psychiatry 57:5, pages 661-674.
Crossref
Crossref
Steven R. Erickson, Jennifer L. Jones, Kami L. Gallus, Amy Esler & James Houseworth. (2021) Potential Drug Interactions in Medication Regimens of Adults who have Intellectual and Developmental Disabilities. Journal of Developmental and Physical Disabilities 34:5, pages 795-828.
Crossref
Crossref
Markus Weih, Sabine Köhler, Norbert Schöll, Mandy Schulz & Ramona Hering. (2022) Mental, neurological, and somatic comorbidities and their treatment in persons with intellectual disability. Deutsches Ärzteblatt international.
Crossref
Crossref
Steven R. Erickson, James Houseworth & Amy Esler. (2022) Factors associated with use of medication for behavioral challenges in adults with intellectual and developmental disability. Research in Developmental Disabilities 123, pages 104182.
Crossref
Crossref
Katrien PM Pouls, Monique CJ Koks-Leensen, Mathilde Mastebroek, Geraline L Leusink & Willem JJ Assendelft. (2022) Adults with intellectual disabilities and mental health disorders in primary care: a scoping review. British Journal of General Practice 72:716, pages e168-e178.
Crossref
Crossref
Shoumitro Shoumi Deb, Marco O. Bertelli & Michele Rossi. 2022. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder
247
279
.
Gerda Margaretha de Kuijper & Albert Willem Lenderink. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
4561
4581
.
Edward da Costa, Danielle Adams, Munzer Salmeh, Omar Mahmoud & Ekim Yetkili. (2021) Using clinical audit to improve the quality of mental health-care services for people with learning disabilities. Advances in Mental Health and Intellectual Disabilities 15:4, pages 105-118.
Crossref
Crossref
Fintan Sheerin, Jessica Eustace-Cook, Francesca Wuytack & Carmel Doyle. (2019) Medication management in intellectual disability settings: A systematic review. Journal of Intellectual Disabilities 25:2, pages 242-276.
Crossref
Crossref
Gerda Margaretha de Kuijper & Albert Willem Lenderink. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
21
.
Elizabeth Jane Evans & Julian Norman Trollor. 2021. Mental Health, Intellectual and Developmental Disabilities and the Ageing Process. Mental Health, Intellectual and Developmental Disabilities and the Ageing Process
189
205
.
M. McMahon, C. Hatton & D. L. Bowring. (2020) Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross‐sectional total population study. Journal of Intellectual Disability Research 64:11, pages 834-851.
Crossref
Crossref
Steven R. Erickson. (2020) In-home comprehensive medication reviews for adults with intellectual or developmental disability: A pilot study. Journal of the American Pharmacists Association 60:6, pages e279-e291.
Crossref
Crossref
Hanna Edberg, Qi Chen, Peter Andiné, Henrik Larsson & Tatja Hirvikoski. (2020) Clinical Characteristics and Pharmacological Treatment of Individuals With and Without Intellectual Disability in Pre-trial Assessment—A Population-Based Study. Frontiers in Psychiatry 11.
Crossref
Crossref
S. Maas, D. A. M. Festen, T. I. M. Hilgenkamp & A. Oppewal. (2020) The association between medication use and gait in adults with intellectual disabilities. Journal of Intellectual Disability Research.
Crossref
Crossref
Angela Henderson, Paula Mcskimming, Deborah Kinnear, Colin McCowan, Alasdair McIntosh, Linda Allan & Sally-Ann Cooper. (2020) Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study. BMJ Open 10:9, pages e036862.
Crossref
Crossref
Laura St. JohnGregory BorschneckJohn Cairney. (2020) A Systematic Review and Meta-Analysis Examining the Effect of Exercise on Individuals With Intellectual Disability. American Journal on Intellectual and Developmental Disabilities 125:4, pages 274-286.
Crossref
Crossref
Shikha Gupta, Mary Ann McColl, Sara J. T. Guilcher & Karen Smith. (2019) An Adapted Model of Cost-Related Nonadherence to Medications Among People With Disabilities. Journal of Disability Policy Studies 31:1, pages 35-45.
Crossref
Crossref
Steven R. EricksonNeil KamdarChung-Hsuen Wu. (2020) Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those Without. American Journal on Intellectual and Developmental Disabilities 125:1, pages 37-48.
Crossref
Crossref
M. Song, R. Ware, T. N. Doan & D. Harley. (2019) Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study. Journal of Intellectual Disability Research 64:1, pages 45-56.
Crossref
Crossref
Danielle Adams & Barry Jubraj. 2020. Promoting the Health and Well-Being of People with Learning Disabilities. Promoting the Health and Well-Being of People with Learning Disabilities
89
106
.
Darren L. Bowring, Jon Painter & Richard P. Hastings. (2019) Prevalence of Challenging Behaviour in Adults with Intellectual Disabilities, Correlates, and Association with Mental Health. Current Developmental Disorders Reports 6:4, pages 173-181.
Crossref
Crossref
Raya Elfadel Kheirbek, Ali Fokar, John T Little, Marshall Balish, Nawar M Shara, Malaz A Boustani & Maria Llorente. (2019) Association Between Antipsychotics and All-Cause Mortality Among Community-Dwelling Older Adults. The Journals of Gerontology: Series A 74:12, pages 1916-1921.
Crossref
Crossref
L. M. Ward, S. A. Cooper, L. Hughes‐McCormack, L. Macpherson & D. Kinnear. (2019) Oral health of adults with intellectual disabilities: a systematic review. Journal of Intellectual Disability Research 63:11, pages 1359-1378.
Crossref
Crossref
Megan V. A. Smith, Danielle Adams, Claudia Carr & Silvana E. Mengoni. (2019) Do people with intellectual disabilities understand their prescription medication? A scoping review. Journal of Applied Research in Intellectual Disabilities 32:6, pages 1375-1388.
Crossref
Crossref
Rohit Shankar, Mike Wilcock, Shoumitro Deb, Rebecca Goodey, Eve Corson, Charlotte Pretorius, Georgina Praed, Amanda Pell, Dee Vujkovic, Ellen Wilkinson, Richard Laugharne, Sharon Axby, Rory Sheehan & Regi Alexander. (2019) A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience. Journal of Applied Research in Intellectual Disabilities 32:6, pages 1389-1400.
Crossref
Crossref
Anna Axmon, Gerd Ahlström, Rebecca Gagnemo Persson & Jonas Eberhard. (2019) Demographic and diagnostic profiles of older people with intellectual disability and prescription of antipsychotics. Social Psychiatry and Psychiatric Epidemiology 54:8, pages 937-944.
Crossref
Crossref
Claire O'Dwyer, Philip McCallion, Martin Henman, Mary McCarron, Eva O'Leary, Eilish Burke, Juliette O'Connell & Máire O'Dwyer. (2019) Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities 32:4, pages 981-993.
Crossref
Crossref
Amy Esler, Amy Hewitt, Jennifer Hall-Lande, Sandra L. Pettingell & James Houseworth. (2019) Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States. Journal of Autism and Developmental Disorders 49:6, pages 2291-2303.
Crossref
Crossref
Oddbjørn Hove, Eva Biringer, Odd E. Havik, Jörg Assmus, Kirsten J. Braatveit, Silje Elisabeth Hasmo Holm & Monica Hermann. (2019) Prevalence of drug use among adults with intellectual disabilities compared with drug use in the general population. Pharmacoepidemiology and Drug Safety 28:3, pages 337-344.
Crossref
Crossref
Annabel Folch, Luis Salvador‐Carulla, Paloma Vicens, Maria José Cortés, Marcia Irazábal, Silvia Muñoz, Lluís Rovira, Carmen Orejuela, Juan A. González & Rafael Martínez‐Leal. (2018)
Health indicators in intellectual developmental disorders: The key findings of the
POMONA
‐
ESP
project
. Journal of Applied Research in Intellectual Disabilities 32:1, pages 23-34.
Crossref
Crossref
Meindert Haveman. 2019. Physical Health of Adults with Intellectual and Developmental Disabilities. Physical Health of Adults with Intellectual and Developmental Disabilities
305
333
.
Gemma L. Unwin, Shoumitro Deb & John Rose. 2019. Handbook of Intellectual Disabilities. Handbook of Intellectual Disabilities
843
868
.
Andrea Koch, Julia Dobrindt & Matthias Schützwohl. (2018) Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany. BMJ Open 8:12, pages e025947.
Crossref
Crossref
Maire O’Dwyer, Philip McCallion, Mary McCarron & Martin Henman. (2018) Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research. Therapeutic Advances in Drug Safety 9:9, pages 535-557.
Crossref
Crossref
Carmela Salomon, Helena Britt, Allan Pollack & Julian Trollor. (2018) Primary care for people with an intellectual disability — what is prescribed? An analysis of medication recommendations from the BEACH dataset. BJGP Open 2:2, pages bjgpopen18X101541.
Crossref
Crossref
Anna Axmon, Magnus Sandberg, Gerd Ahlström & Patrik Midlöv. (2018) Fall-risk-increasing drugs and falls requiring health care among older people with intellectual disability in comparison with the general population: A register study. PLOS ONE 13:6, pages e0199218.
Crossref
Crossref
Teresa M Salgado, Alexa Fedrigon, Donna Riccio Omichinski, Michelle A Meade & Karen B Farris. (2018) Identifying Medication Management Smartphone App Features Suitable for Young Adults With Developmental Disabilities: Delphi Consensus Study. JMIR mHealth and uHealth 6:5, pages e129.
Crossref
Crossref
Anna Axmon, Magnus Sandberg, Gerd Ahlström & Patrik Midlöv. (2017) Prescription of potentially inappropriate medications among older people with intellectual disability: a register study. BMC Pharmacology and Toxicology 18:1.
Crossref
Crossref
Iain M Carey, Fay J Hosking, Tess Harris, Stephen DeWilde, Carole Beighton & Derek G Cook. (2017) An evaluation of the effectiveness of annual health checks and quality of health care for adults with intellectual disability: an observational study using a primary care database. Health Services and Delivery Research 5:25, pages 1-170.
Crossref
Crossref
D. L. Bowring, V. Totsika, R. P. Hastings, S. Toogood & M. McMahon. (2017) Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study. Journal of Intellectual Disability Research 61:6, pages 604-617.
Crossref
Crossref
J. Weise, A. Pollack, H. Britt & J. N. Trollor. (2017) Primary health care for people with an intellectual disability: an exploration of consultations, problems identified, and their management in Australia. Journal of Intellectual Disability Research 61:5, pages 399-410.
Crossref
Crossref
이숙향 & 홍주희. (2017) Review of Supports and Future Directions to Promote Access to Health and Medical Services for People with Disabilities. Korean Journal of Physical, Multiple, & Health Disabilities 60:2, pages 1-31.
Crossref
Crossref
Anna Axmon, Jimmie Kristensson, Gerd Ahlström & Patrik Midlöv. (2017) Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia. Research in Developmental Disabilities 62, pages 50-57.
Crossref
Crossref
Steven R. Erickson, Teresa M. Salgado & Xi Tan. (2016) Issues in the Medication Management Process in People Who Have Intellectual and Developmental Disabilities: A Qualitative Study of the Caregivers' Perspective. Intellectual and Developmental Disabilities 54:6, pages 412-426.
Crossref
Crossref
Maurice A. Feldman, Frances Owen, Amy E. Andrews, Munazza Tahir, Rachel Barber & Dorothy Griffiths. (2016) Randomized Control Trial of the 3Rs Health Knowledge Training Program for Persons with Intellectual Disabilities. Journal of Applied Research in Intellectual Disabilities 29:3, pages 278-288.
Crossref
Crossref
Kate M Chitty, Elizabeth Evans, Jennifer J Torr, Teresa Iacono, Henry Brodaty, Perminder Sachdev & Julian N Trollor. (2015) Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study. Australian & New Zealand Journal of Psychiatry 50:4, pages 352-362.
Crossref
Crossref
Máire O'Dwyer, Jure Peklar, Philip McCallion, Mary McCarron & Martin C Henman. (2016) Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open 6:4, pages e010505.
Crossref
Crossref
Shoumitro Deb. 2016. Handbook of Evidence-Based Practices in Intellectual and Developmental Disabilities. Handbook of Evidence-Based Practices in Intellectual and Developmental Disabilities
347
381
.
Sally-Ann Cooper, Gary McLean, Bruce Guthrie, Alex McConnachie, Stewart Mercer, Frank Sullivan & Jill Morrison. (2015) Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis. BMC Family Practice 16:1.
Crossref
Crossref
Susan Kelly & Yani Su. (2015) Psychotropic and Anticonvulsant Medication: Individuals With Intellectual and Developmental Disabilities Who Transitioned to the Community From an Institution. Intellectual and Developmental Disabilities 53:4, pages 289-300.
Crossref
Crossref
Johannes Salb, Carol Woodward, Jens Offenhäußer, Clemens Becker, Cornel Sieber & Ellen Freiberger. (2015) Prevalence and Characteristics of Falls in Adults with Intellectual Disability Living in a Residential Facility: A Longitudinal Study [PreFallID]. Intellectual and Developmental Disabilities 53:3, pages 228-239.
Crossref
Crossref
S. Deb, G. Unwin & T. Deb. (2015) Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour. Journal of Intellectual Disability Research 59:1, pages 11-25.
Crossref
Crossref
Shang-Wei Hsu, Po-Huang Chiang, Yu-Chia Chang, Jin-Ding Lin, Ho-Jui Tung & Chao-Yun Chen. (2014) Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: A nationwide outpatient service study, 1997–2007. Research in Developmental Disabilities 35:2, pages 364-372.
Crossref
Crossref
Tan Doan, Robert Ware, Lyn McPherson, Kate van Dooren, Christopher Bain, Suzanne Carrington, Stewart Einfeld, Bruce Tonge & Nicholas Lennox. (2014) Psychotropic medication use in adolescents with intellectual disability living in the community. Pharmacoepidemiology and Drug Safety 23:1, pages 69-76.
Crossref
Crossref